SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about resignation of independent director

26 Feb 2020 Evaluate

Bal Pharma has informed that with reference to Regulation 30 of SEBI (LODR) Regulations, 2015 and further to intimation dated 25/02/2020 regarding resignation of Pramod Kumar.S as independent Director of the Company; the Company has submitting the confirmation received from Pramod Kumar.S as per Regulation 30, Clause 7B of Schedule III of SEBI(LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

77.19 -1.28 (-1.63%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×